Evidence map›Paper›PMID 30227629›Full record

ReviewInternational journal of molecular sciences2018

Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy.

Sungmin Lee, Beomseok Son, Gaeul Park, Hyunwoo Kim, Hyunkoo Kang, Jaewan Jeon, HyeSook Youn, BuHyun Youn

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sungmin LeeDepartment of Integrated Biological Science, Pusan National University, Busan 46241, Korea. smlee1048@gmail.com.
Beomseok SonDepartment of Integrated Biological Science, Pusan National University, Busan 46241, Korea. beomseok15@gmail.com.
Gaeul ParkDepartment of Integrated Biological Science, Pusan National University, Busan 46241, Korea. gaeulpark91@gmail.com.
Hyunwoo KimDepartment of Integrated Biological Science, Pusan National University, Busan 46241, Korea. harlemkim@gmail.com.
Hyunkoo KangDepartment of Integrated Biological Science, Pusan National University, Busan 46241, Korea. kanghk94@gmail.com.
Jaewan JeonDepartment of Integrated Biological Science, Pusan National University, Busan 46241, Korea. jjwej1066@gmail.com.
HyeSook YounDepartment of Integrative Bioscience and Biotechnology, Sejong University, Seoul 05006, Korea. hsyoun@sejong.ac.kr.
BuHyun YounDepartment of Integrated Biological Science, Pusan National University, Busan 46241, Korea. bhyoun72@pusan.ac.kr.

Funding

National Research Foundation of Korea 2016R1D1A1B03931405National Research Foundation of Korea 2017R1D1A1B03028769
6 · The paper itself

Abstract

Hyperthermia is a cancer treatment where tumor tissue is heated to around 40 °C. Hyperthermia shows both cancer cell cytotoxicity and immune response stimulation via immune cell activation. Immunogenic responses encompass the innate and adaptive immune systems, involving the activation of macrophages, natural killer cells, dendritic cells, and T cells. Moreover, hyperthermia is commonly used in combination with different treatment modalities, such as radiotherapy and chemotherapy, for better clinical outcomes. In this review, we will focus on hyperthermia-induced immunogenic effects and molecular events to improve radiotherapy efficacy. The beneficial potential of integrating radiotherapy with hyperthermia is also discussed.

Indexed as

AnimalsCombined Modality TherapyHumansHyperthermia, InducedImmunity, CellularImmunity, InnateImmunotherapyNeoplasmsRadiotherapycombination therapyhyperthermiaimmunotherapyradiotherapy

Identifiers

PMID30227629
PMCPMC6164993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.